This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Murphy, J R Articles by Clyde, D F Search for Related Content PubMed PubMed Citation Articles by Murphy, J R Articles by Clyde, D F

 Previous Article  |  Next Article 

J Clin Microbiol. 1989 July; 27(7): 1434-1437

Evidence for a 6.5-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infection.

Department of Medicine, University of Maryland School of Medicine, Baltimore 21201.

ABSTRACT

Immunization with a synthetic peptide which is representative of part of the repeating region of Plasmodium falciparum circumsporozoite protein resulted in an immunity which allowed vaccinees to retard the development of patent malaria as compared to nonimmunized controls. Analysis of infection dynamics showed that immunity could be attributed to either neutralization of about 92% of inoculated sporozoites, delayed development of the majority of parasites, or a combination of neutralization and delayed development. In spite of this impressive antiplasmodial capacity, all volunteers after being bitten by infected mosquitoes developed malaria, and seven of eight developed parasitemia between 6.5 and 7.0 days after infective mosquito bites.

This article has been cited by other articles:

• SATTABONGKOT, J., YIMAMNUAYCHOKE, N., LEELAUDOMLIPI, S., RASAMEESORAJ, M., JENWITHISUK, R., COLEMAN, R. E., UDOMSANGPETCH, R., CUI, L., BREWER, T. G. (2006). ESTABLISHMENT OF A HUMAN HEPATOCYTE LINE THAT SUPPORTS IN VITRO DEVELOPMENT OF THE EXO-ERYTHROCYTIC STAGES OF THE MALARIA PARASITES PLASMODIUM FALCIPARUM AND P. VIVAX.. Am J Trop Med Hyg 74: 708-715 [Abstract] [Full Text]  
• Kawabata, Y., Udono, H., Honma, K., Ueda, M., Mukae, H., Kadota, J.-i., Kohno, S., Yui, K. (2002). Merozoite Surface Protein 1-Specific Immune Response Is Protective against Exoerythrocytic Forms of Plasmodium yoelii. Infect. Immun. 70: 6075-6082 [Abstract] [Full Text]